Searched for
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Two Trades for Today: A passenger vehicle maker for a 4.8% upmove, a mid-cap pharma stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- Two Trades for Today: A two-wheeler maker for a 4.8% rise, a mid-cap tyre maker’s stock for a gain of about 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- Telangana bets big on drug discovery hubTelangana is gearing up to elevate Hyderabad's pharmaceutical standing beyond manufacturing. The state is fostering an integrated ecosystem...
- Logistics player A1 expands industrial chemical portfolioA 1 Ltd, a logistics and chemical supplier, has been appointed the Primary Authorised Dealer for Ishan Dyes and Chemicals Ltd's sulphur-bas...
- Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...
- Adani Ports says MSC’s terminal arm TiL will invest $1.4 billion for 49% stake in Vizhinjam PortAdani Ports has partnered with MSC Group's TiL, which will invest $1.397 billion for a 49% stake in Vizhinjam Port. This significant foreig...
- Hyderabad is India's most expensive GCC office market, commands 15% premiumHyderabad has emerged as India's priciest office market for Global Capability Centres (GCCs), commanding a 15% premium. The city leads the ...
- Tamil Nadu based Stalwart People Services files DRHP for Rs 150 crore IPOTamil Nadu-based Stalwart People Services has filed its DRHP with Sebi to raise Rs 150 crore through a fresh issue of shares, alongside an ...
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
Load More
